Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2005-04-18 | Dr. Howell is a Professor of Medicine at the University of California, San Diego. |
2006-04-25 | Dr. Howell is a Professor of Medicine at the University of California, San Diego, and director of the Cancer Pharmacology Program of the UCSD Cancer Center. |
2007-04-13 | Dr. Howell is a Professor of Medicine at the University of California, San Diego. |
2008-04-22 | Dr. Howell is a Professor of Medicine at the University of California, San Diego. |
2009-04-22 | Dr. Howell is a Professor of Medicine at the University of California, San Diego. |
2010-04-16 | Stephen B. Howell, M.D. has served as our director since 1996. Dr. Howell is a member of the Compensation Committee of the Board. |
2011-04-14 | Dr. Howell’s qualifications to serve our Board include his technical expertise and strong commitment to promoting and advancing innovation in the healthcare industry. |
2012-04-16 | Dr. Howell’s qualifications to serve our Board include his technical expertise and strong commitment to promoting and advancing innovation in the healthcare industry. |
2013-04-02 | Stephen B. Howell, M.D. has served as our director since 1996. |
2014-04-15 | Dr. Howell is a member of the Compensation Committee of the Board. Dr. Howell is a Professor of Medicine at the University of California, San Diego, and director of the Cancer Pharmacology Program of the UCSD Cancer Center. |
2015-04-07 | Dr. Howell's qualifications to serve our Board include his technical expertise and strong commitment to promoting and advancing innovation in the healthcare industry. |
2016-04-06 | Dr. Howell has been Professor of Medicine at the University of California, San Diego since 1977. |
2017-04-11 | Dr. Howell’s qualifications to serve our Board include his technical expertise and strong commitment to promoting and advancing innovation in the healthcare industry. |
2018-04-10 | Dr. Howell’s qualifications to serve our Board include his technical expertise and strong commitment to promoting and advancing innovation in the healthcare industry. |
2019-04-11 | Dr. Howell’s qualifications to serve on our Board include his technical expertise and strong commitment to promoting and advancing innovation in the healthcare industry. |
2020-04-10 | Dr. Howell’s qualifications to serve on our Board include his technical expertise and strong commitment to promoting and advancing innovation in the healthcare industry. |
Data sourced from SEC filings. Last updated: 2025-07-01